Citations

Clear

15427 citation(s) found for "Su, Michael".

Five-year survival and complications of more than 300 articulating high-dose antibiotic spacers in two-stage revision total hip arthroplasties for infection
Weintraub, Matthew T. , Midthun, William R., Pagnano, Mark W., Taunton, Michael J. , Sierra, Rafael J. , Mabry, Tad M. , Perry, Kevin I. , Abdel, Matthew P. , Abdel, Matthew P , Sierra, Rafael J , Taunton, Michael J , Pagnano, Mark W. , Berry, Daniel J.

Mayo Clinic

The Bone & Joint Journal | September 1, 2026 | Volume: 108-B | Issue: 9 | Pages: 1104-1112

10.1302/0301-620x.108b9.bjj-2026-0551.r1 | PMID 42674571 Get It

Aims Two-stage exchange arthroplasty with an antibiotic-eluting cement spacer remains the predominant strategy in the USA for managing chronic periprosthetic joint infection (PJI) following total hip arthroplasty (THA). The aim of this study was to evaluate a commercially available, partially intraoperatively fabricated articulating high-dose antibiotic cement spacer, focusing on survival, complications, and patient-reported outcomes. Methods A total of 298 patients (302 THAs) underwent two-stage exchange arthroplasty for PJI using a specific articulating antibiotic spacer between August 2005 and May 2022. Patients with a previous failed two-stage exchange were excluded, although 121 THAs (302, 40%) had undergone previous PJI-related procedures. The mean age of the patients was 65 years (SD 11), the mean BMI was 32 kg/m 2 (SD 7), and 116 (38%) were female. Most patients were classified as McPherson host B (158; 52%) and limb grade 2 (165; 55%), and 265 (88%) met the 2011 Musculoskeletal Infection Society criteria. The mean follow-up was six years (2 to 16). Results At five years after reimplantation, survival free of reinfection, aseptic rerevision, any rerevision, or any reoperation were 89% (95% CI 85.2 to 93.1), 93% (95% CI 89.3 to 96.1), 86% (95% CI 81.3 to 90.3), and 80% (95% CI 74.7 to 84.9), respectively. Dislocation accounted for most aseptic rerevisions (15/20). McPherson host C (HR 3.7 (95% CI 1.4 to 9.6); p = 0.007) and limb grade 3 (HR 3.3 (95% CI 1.0 to 11.1); p = 0.049) were significantly associated with an increased risk of reinfection. The mean Harris Hip Score at the latest follow-up was 76 (29 to 100). A total of 17 patients underwent revision or removal of a spacer for concerns about persistent infection and two for dislocation of the spacer. Eight patients underwent a non-rerevision reoperation during the spacer interval for wound drainage (n = 5), dislocation of the spacer (n = 2), and perispacer fracture (n = 1). A total of 26 spacer-related complications were treated nonoperatively (15 perispacer fractures, 11 dislocations). Dislocation of the spacer was strongly associated with dislocation after reimplantation (HR 6.2 (95% CI 2.3 to 16.9); p < 0.001). Conclusion This commercially available, partially intraoperatively fabricated articulating spacer showed excellent reinfection-free five-year survival (89%). Spacer-related fracture and dislocation each occurred in 5% of patients. Dislocation of the spacer significantly increased the risk of dislocation following reimplantation, supporting the use of higher-stability bearings in these high-risk patients. Cite this article: Bone Joint J 2026;108-B(9):1104–1112.
Prognostic Value of Artificial Intelligence ECG–Derived Diastolic Function in Surgical Aortic Valve Replacement
Sawma, Tedy , Schaff, Hartzell V. , Danesh, Sina , Arghami, Arman , Lee, Eunjung , Aslahishahri, Masoomeh, Stulak, John, Greason, Kevin L. , Dearani, Joseph A. , López-Jiménez, Francisco , Friedman, Paul A. , Oh, Jae K. , Dearani, Joseph A. , Greason, Kevin , Sabbah, Michael S. , Attia, Zachi I , Oh, Jae K. , Crestanello, Juan A , Lopez-Jimenez, Francisco , Arghami, Arman , Schaff, Hartzell , Stulak, John M., Pislaru, Sorin V. , Attia, Zachi I. , Crestanello, Juan A.

Mayo Clinic

Journal of the American Heart Association | August 31, 2026 | Volume: 15 | Issue: 19 | Pages: No page available

10.1161/jaha.126.050492 | PMID 42669926 Get It

Background Diastolic dysfunction is common in patients with aortic stenosis and may influence outcomes following surgical aortic valve replacement. We aimed to examine the association of preoperative artificial intelligence (AI)‐generated diastolic function grades with early and late outcomes following aortic valve replacement and how postoperative progression influence prognosis. Methods We identified 5503 patients undergoing aortic valve replacement between 2000 and 2023. Diastolic function was assessed using a validated deep‐learning AI model applied to 12‐lead ECGs done preoperatively and on postoperative follow‐up. Diastolic grades were classified by AI into Grades 1 to 3. Longitudinal trend analyses and multivariable regression models were used to assess study end points. Results Among 5503 patients (mean age 72.4±10.8 years; 39% female), higher AI ECG diastolic grades were associated with greater comorbidity burden, including diabetes, renal disease, and heart failure. AI ECG diastolic Grade 3 was independently associated with higher in‐hospital mortality (odds ratio, 2.5; P =0.007) and other complications. At 5‐year follow‐up, patients with Grade 3 showed the least improvement in diastolic function by both ECG and echocardiography. Grades 2 and 3 diastolic function at baseline were independently associated with increased late mortality (hazard ratio, 1.3 and 2.45, respectively; both P <0.001). Additionally, lack of improvement in AI ECG diastolic grade by 1 year was also independently associated with late mortality. Conclusions AI ECG–derived diastolic function grades strongly correlates with early complications and long‐term mortality and diastolic progression after aortic valve replacement. AI ECG provides a powerful, noninvasive tool for risk stratification and longitudinal monitoring of patients with aortic stenosis.
Temporal variation in sexually transmitted infection diagnoses across the lunar infradian rhythm: an 8-year retrospective analysis
Beel, Brittany C. , Monas, Jessica , Hodgson, Nicole R. , Wallace, Alyssa K., Sheele, Johnathan M. , Mohseni, Michael , Mohseni, Michael M

Mayo Clinic

Biological Rhythm Research | August 28, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-13

10.1080/09291016.2026.2724529 Get It

Brain multiomic profiling identifies tau-related transcriptomic dysregulation in Alzheimer’s disease
Oatman, Stephanie R., Quicksall, Zachary , Wang, Xue, Bergman, Jeremiah, Reddy, Joseph S, Vanelderen, Floor , Nguyen, Thuy , Malphrus, Kimberly, Lincoln, Sarah, Martens, Yuka A. , Zhao, Na, Yamazaki, Yu, DeTure, Michael, Bu, Guojun, Kanekiyo, Takahisa , Allen, Mariet , Ertekin‐Taner, Nilüfer , Lincoln, Sarah J, Murray, Melissa E , Kanekiyo, Takahisa , Dickson, Dennis W , Ertekin-Taner, Nilüfer , Reddy, Joseph S. , Malphrus, Kimberly G., Yamazaki, Yu , DeTure, Michael , Murray, Melissa E. , Liu, Chia‐Chen , Bu, Guojun , Dickson, Dennis W.

Mayo Clinic

Brain Communications | August 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/braincomms/fcag326 | PMID 42712681 Get It

Abstract Identification of gene expression changes in post-mortem brain tissue of Alzheimer’s disease donors compared to controls have implicated numerous biological pathways for Alzheimer’s disease pathophysiology. Nonetheless, there is still limited understanding of how gene expression dysregulation underpins specific proteinopathies core to Alzheimer’s disease. Here we investigate brain transcriptomic changes in a well characterized cohort of Alzheimer’s disease donors to identify genes and networks that associate with Alzheimer’s disease endophenotypes including neuropathology measures (Braak stage, Thal phase and cerebral amyloid angiopathy score) and Alzheimer’s disease-related brain protein levels (Apolipoprotein E, Amyloid-β 40, Amyloid-β 42, tau, and phospho-Tau). Bulk transcriptome measures were collected from the temporal cortex tissue of 477 Alzheimer’s disease donors. Following quality control, transcriptome-wide association studies were performed for each endophenotype. We used weighted gene co-expression network analysis to build co-expression networks and integrated transcriptome with epigenetic and genetic data from the same donors. We detected a total of 5,740 Bonferroni significant temporal cortex gene associations with Alzheimer’s disease endophenotypes, most of which were with brain tau levels. We discovered tau-associated co-expression modules enriched in known and novel Alzheimer’s disease pathways. We found that a beneficial (or neutral) brain biochemical state of higher total tau and lower phospho-Tau are associated with increased levels of synaptic, DNA damage/repair, nucleic acid metabolism and myelin processes. In contrast, in a detrimental state of lower total and higher phospho-Tau, there is upregulation of vascular and immune, and downregulation of mitochondrial and myelin pathways. There are brain gene expression perturbations that are associated with Alzheimer’s disease endophenotypes. While some of these associations are common across multiple endophenotypes, many are distinct for different Alzheimer’s disease-related proteins. Based on these findings, we propose a hypothetical model of dynamic brain gene expression changes that track with progressive Alzheimer’s disease proteostasis. These expression changes hold potential to serve as dynamic, precision biomarkers of brain Alzheimer’s disease progression. This study demonstrates the potential of integrative multiomics and deep Alzheimer’s disease endophenotype analyses in well-characterized brain tissues to uncover with precision the complex biology of Alzheimer’s disease.
Hemodynamic Changes After Transcatheter Valve Repair and Replacement for Tricuspid Regurgitation
Pislaru, Sorin V. , Alkhouli, Mohamad , Guerrero, Mayra , Simard, Trevor , Hibbert, Benjamin , Alabdaljabar, Mohamad S. , Alabdaljabar, Mohamad S , Elhadi, Mohamed , Thaden, Jeremy J , Padang, Ratnasari , Sabbah, Michael S. , Hibbert, Benjamin , Simard, Trevor , Alkhouli, Mohamad , Guerrero, Mayra E , Rihal, Charanjit S. , Eleid, Mackram F , Thaden, Jeremy J. , Padang, Ratnasari , Eleid, Mackram F.

Mayo Clinic

Journal of the American Heart Association | August 27, 2026 | Volume: 15 | Issue: 17 | Pages: No page available

10.1161/jaha.126.050310 | PMID 42657747 Get It

Background Transcatheter edge‐to‐edge repair (TEER) and replacement (TTVR) have emerged as new modalities to treat patients with symptomatic significant tricuspid regurgitation. This study aimed to compare invasive hemodynamic and right ventricular (RV) changes and symptom improvement over 1 year. Methods Patients who underwent TEER/TTVR at Mayo Clinic (Rochester, MN, 2017–2024) were included. Hemodynamic profiles were described before and immediately after intervention, in addition to RV enlargement/dysfunction ≥moderate at 30 days and change in symptoms over time. Results Of 100 patients included (50 per group, median age 81 versus 80 years and female 62% versus 42%, in TTVR and TEER, respectively), all had ≥ moderate–severe symptomatic tricuspid regurgitation. Post intervention, mean right atrial pressure decreased in TEER (16 to 14 mm Hg, P <0.001), V wave decreased in both groups (to 16 mm Hg, P <0.001). RV enlargement was less prevalent in both cohorts at 30 days (60%–40% in TEER, P =0.01, and 72 to 58% in TTVR, P =0.07), yet prevalence of RV dysfunction decreased only in TEER (26 to 15%, P =0.17) as opposed to TTVR (31 to 44%, P =0.13). TTVR resulted in a higher stroke volume index and more complete tricuspid regurgitation elimination at 30 days. Both groups resulted in similar improvements in New York Heart Association class, with overall similar survival. Conclusions TEER was associated with a greater reduction in right atrial pressure and more favorable RV remodeling at 30 days, as opposed to TTVR, which achieved more complete and sustained elimination of tricuspid regurgitation with higher forward stroke volume.
Cannabinoid Hyperemesis Syndrome
Venkatesan, Thangam , Hasler, William L. , Camilleri, Michael

Mayo Clinic

JAMA | August 26, 2026 | Volume: 336 | Issue: 18 | Pages: 1642

10.1001/jama.2026.7873 | PMID 42647032 Get It

This JAMA Insights discusses cannabinoid hyperemesis syndrome, including pathophysiology, clinical presentation, and the epidemiology and risk factors.
Mortality risk after traumatic fractures in autofused spines from ankylosing spondylitis or DISH: age may matter more than treatment
Pennington, Zach, El-Gohary, Mohamed M., Lakomkin, Nikita, Ransom, Seth, Dennison, Stanley, Obiri-Yeboah, Derrick, Martini, Michael L., Kendall, Nicholas, Gharibi, Orod , Owens, Virgenal, Krauss, William E. , Helgeson, Melvin D. , Sebastian, Arjun S. , Mikula, Anthony L. , Fogelson, Jeremy L. , Freedman, Brett A., Elder, Benjamin D., Pennington, Zach , Pennington, Zach , Hamouda, Abdelrahman M. , Lakomkin, Nikita , Ransom, Seth C. , Owens, Virgenal, Clarke, Michelle J. , Nassr, Ahmad , Freedman, Brett Arthur , Elder, Benjamin D.

Mayo Clinic

Journal of Neurosurgery: Spine | August 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-11

10.3171/2026.4.spine251776 | PMID 42664512 Get It

OBJECTIVE Multisegmental pathological autofusion is a hallmark feature of ankylosing spondylitis (AS) and diffuse idiopathic skeletal hyperostosis (DISH), creating a rigid, brittle spine highly susceptible to three-column fractures and devastating neurological injury. This study aimed to evaluate survival outcomes in this patient population and identify clinical and demographic predictors of mortality. METHODS Adults with DISH or AS who sustained a fracture and were admitted to a single tertiary care center for spinal fracture were retrospectively identified using ICD-10 diagnostic codes. Data were extracted on demographics, clinical presentation, fracture characteristics, and details of treatment. RESULTS A total of 383 patients (median age 78 years, 75.2% male) were included. Over a median follow-up of 17.3 months, overall mortality was 38.1%, in-hospital mortality was 5.2%, 30-day mortality was 5.7%, and 1-year mortality was 18.0%. Initial treatment consisted of external orthosis in 220 (57.4%) and surgery in 144 (37.6%), while 19 (5.0%) were left untreated. Patients who died were older (median 83 vs 74 years, p < 0.001), had a lower BMI (29.4 vs 32.3 kg/m 2 , p < 0.001), had higher frailty on the 5-item modified frailty index (mFI-5), and more commonly had congestive heart failure (CHF), cancer, functional dependency, and chronic kidney disease (CKD) (all p < 0.01). Mortality was not associated with fracture location, mechanism of injury, fracture number, or the presence of neurological deficits. Univariable time-to-event analysis showed that decreased survival was predicted by older age (HR 1.08, p < 0.0001), lower BMI (HR per kg/m 2 0.93, p < 0.0001), functional dependency (HR 2.05, p < 0.001), cancer (HR 1.55 p = 0.01), CKD (HR 1.48, p = 0.019), CHF (HR 2.18, p < 0.001), and higher mFI-5 score (HR per point 1.34, p < 0.001). On multivariable analysis, older age (HR 1.06 per year, p < 0.001), lower BMI (HR per kg/m 2 0.95, p < 0.001), and mFI-5 score (HR per patient 1.37, p < 0.001) remained significant independent predictors of mortality. Treatment modality did not predict mortality. CONCLUSIONS AS- or DISH-associated spinal fractures have a high associated mortality, regardless of mechanism or severity. Treatment modality did not affect odds of survival, suggesting that nonoperative management with an external orthosis may be an appropriate option, particularly in older and medically complex patients.